Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top
Radiation Oncology
Published in:

Open Access 29-03-2025 | Radiotherapy | Review

Practical recommendations for the management of radiodermatitis: on behalf of the ESTRO RTT committee

Authors: Elizabeth Forde, Ludwig Van den Berghe, Monica Buijs, Antonella Cardone, Jacqueline Daly, Pierfrancesco Franco, Naman Julka-Anderson, Wolfgang Lechner, Laure Marignol, Giulia Marvaso, Heather Nisbet, Anita O’Donovan, Nicola S. Russell, Philipp Scherer

Published in: Radiation Oncology | Issue 1/2025

Login to get access

Abstract

Background

There is a substantial body of literature addressing the prevention, acute management, and follow-up care of radiation induced dermatitis (RID). The quality and application of this evidence, however, is inconsistent and its interpretation varies widely. While several national guidelines have been developed to standardise practices locally, many of these resources are not publicly available. On behalf of the European Society for Radiotherapy and Oncology (ESTRO) Radiation Therapist (RTT) Committee, an international writing group consisting of 12 experts from radiotherapy and two patient representatives composed a recommendation document for the management of RID.

Main body

The consensus for these recommendations was generated based on available international guidelines, and supplemented with evidence-based review articles on the topic. These recommendations focus on the prevention and practical management of early stage RID by avoiding skin trauma and maintaining hygiene. Addressing pain and inflammation in higher grades is also covered. The current literature refutes some of the traditional recommendations, especially restricting washing as well as the use of deodorant or the potential dose build-up of lotions which has been included and rectified in recent guidelines. In addition, the importance of grading the severity, including a baseline assessment is presented. The benefit of clear, and non-contradictory communication within the multidisciplinary team as well as patient involvement (e.g. PROMs or similar) is highlighted. Furthermore, the importance of recognising different skin types and skin tones, and the impact on how RID changes these in their appearance is stressed.

Conclusion

This document provides practical, actionable recommendations for the clinical management of RID, referencing the supporting literature. These recommendations have, however, identified a lack of high-level evidence, especially for agent-specific recommendations.
Appendix
Available only for authorised users
Literature
1.
Lee J, Park W, Choi DH, Huh SJ, Kim IR, Kang D, et al. Patient-reported symptoms of radiation dermatitis during breast cancer radiotherapy: a pilot study. Qual Life Res. 2017;26:1713–9.PubMedCrossRef
2.
Behroozian T, Milton LT, Shear NH, McKenzie E, Razvi Y, Karam I, et al. Radiation dermatitis assessment tools used in breast cancer: a systematic review of measurement properties. Support Care Cancer. 2021;29:2265–78.PubMedCrossRef
3.
Rosenthal A, Israilevich R, Moy R. Management of acute radiation dermatitis: a review of the literature and proposal for treatment algorithm. J Am Acad Dermatol. 2019;81:558–67.PubMedCrossRef
4.
Wickline MM. Prevention and treatment of acute radiation dermatitis: a literature review. Oncol Nurs Forum. 2004;31:237–47.PubMedCrossRef
5.
Wong RK, Bensadoun RJ, Boers-Doets CB, Bryce J, Chan A, Epstein JB, et al. Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer. 2013;21:2933–48.PubMedCrossRef
6.
Iacovelli NA, Galaverni M, Cavallo A, Naimo S, Facchinetti N, Iotti C, et al. Prevention and treatment of radiation-induced acute dermatitis in head and neck cancer patients: a systematic review. Future Oncol. 2018;14:291–305.PubMedCrossRef
7.
Burke G, Faithfull S, Probst H. Radiation induced skin reactions during and following radiotherapy: a systematic review of interventions. Radiography (Lond). 2022;28:232–9.PubMedCrossRef
8.
Behroozian T, Goldshtein D, Ryan Wolf J, van den Hurk C, Finkelstein S, Lam H, et al. MASCC clinical practice guidelines for the prevention and management of acute radiation dermatitis: part 1) systematic review. EClinicalMedicine. 2023;58:101886.PubMedPubMedCentralCrossRef
9.
Finkelstein S, Kanee L, Behroozian T, Wolf JR, van den Hurk C, Chow E, et al. Comparison of clinical practice guidelines on radiation dermatitis: a narrative review. Support Care Cancer. 2022;30:4663–74.PubMedCrossRef
10.
11.
12.
13.
14.
Gosselin T, Ginex PK, Backler C, Bruce SD, Hutton A, Marquez CM, et al. ONS guidelines for cancer treatment-related radiodermatitis. Oncol Nurs Forum. 2020;47:654–70.PubMedCrossRef
15.
16.
Aarts F. Acute huidreacties bij radiotherapie: de nieuwste inzichten. Nursing. 2019;25:30–5.CrossRef
17.
Vereniging verpleegkundigen radiotherapie en oncologie (VVRO): Protocol voor de verzorging van acute huidreacties tijdens en na radiotherapie (version 3.0) 2021. Available online: https://​vvro.​be.
18.
Vereniging verpleegkundigen radiotherapie en oncologie (VVRO) and Belgische vereniging voor deskundigen in wondzorg (WCS Belgie): Praktische richtlijnen rond Radiodermatitis (version 2.0). 2021.
19.
20.
Behroozian T, Bonomo P, Patel P, Kanee L, Finkelstein S, van den Hurk C, et al. Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidelines for the prevention and management of acute radiation dermatitis: international Delphi consensus-based recommendations. Lancet Oncol. 2023;24:e172–85.PubMedCrossRef
21.
Behroozian T, Caini S, van den Hurk C, Bonomo P, Chow E, Wolf JR. Systematic review and meta-analysis on interventions for radiation dermatitis prevention and management: an overview of the methods. Support Care Cancer. 2023;31:261.PubMedCrossRef
22.
Fatima S, Hirakawa S, Marta GN, Caini S, Beveridge M, Bonomo P, et al. Topical non-steroidal agents for the prevention of radiation dermatitis: a systematic review and meta-analysis. Support Care Cancer. 2023;31:217.PubMedCrossRef
23.
Gobbo M, Rico V, Marta GN, Caini S, Ryan Wolf J, van den Hurk C, et al. Photobiomodulation therapy for the prevention of acute radiation dermatitis: a systematic review and meta-analysis. Support Care Cancer. 2023;31:227.PubMedPubMedCentralCrossRef
24.
Robijns J, Aquilano M, Banerjee S, Caini S, Wolf JR, van den Hurk C, et al. Barrier films and dressings for the prevention of acute radiation dermatitis: a systematic review and meta-analysis. Support Care Cancer. 2023;31:219.PubMedCrossRef
25.
Robijns J, Becherini C, Caini S, Wolf JR, van den Hurk C, Beveridge M, et al. Natural and miscellaneous agents for the prevention of acute radiation dermatitis: a systematic review and meta-analysis. Support Care Cancer. 2023;31:195.PubMedCrossRef
26.
Salvestrini V, Marta GN, Caini S, Wolf JR, van den Hurk C, Beveridge M, et al. The effect of antiperspirant and deodorant use on acute radiation dermatitis in breast cancer patients during radiotherapy: a systematic review and meta-analysis. Support Care Cancer. 2023;31:198.PubMedCrossRef
27.
e Vasconcelos SCCM, Guerra ENS, de Meneses AG, Dos Reis PED, Ferreira EB. Effects of oral supplementation to manage radiation dermatitis in cancer patients: a systematic review. Support Care Cancer. 2023;31:240.PubMedCrossRef
28.
29.
Mullins BT, Gupta G. Increased radiation toxicity with germline ATM variant of uncertain clinical significance. Rep Pract Oncol Radiother. 2019;24:672–80.PubMedPubMedCentralCrossRef
30.
Begg AC, Russell NS, Knaken H, Lebesque JV. Lack of correlation of human fibroblast radiosensitivity in vitro with early skin reactions in patients undergoing radiotherapy. Int J Radiat Biol. 1993;64:393–405.PubMedCrossRef
31.
Kisonas J, Venius J, Sevriukova O, Grybauskas M, Dabkeviciene D, Burneckis A, et al. Individual radiosensitivity as a risk factor for the radiation-induced acute radiodermatitis. Life (Basel). 2021;12:40.
32.
Lai CC, Wei KC, Chen WY, Mar GY, Wang WH, Wu CS, et al. Risk factors for radiation-induced skin ulceration in percutaneous coronary interventions of chronic total occluded lesions: a 2-year observational study. Sci Rep. 2017;7:8408.PubMedPubMedCentralCrossRef
33.
Chugh R, Bisht YS, Nautiyal V, Jindal R. Factors influencing the severity of acute radiation-induced skin and mucosal toxicity in head and neck cancer. Cureus. 2021;13:e18147.PubMedPubMedCentral
34.
Wright JL, Takita C, Reis IM, Zhao W, Lee E, Nelson OL, et al. Prospective evaluation of radiation-induced skin toxicity in a race/ethnically diverse breast cancer population. Cancer Med. 2016;5:454–64.PubMedPubMedCentralCrossRef
35.
Hume SP, Marigold JC, Michalowski A. The effect of local hyperthermia on nonproliferative, compared with proliferative, epithelial cells of the mouse intestinal mucosa. Radiat Res. 1983;94:252–62.PubMedCrossRef
36.
37.
Arron S. Anatomy of the skin and pathophysiology of radiation dermatitis. In: Fowble BY, Sue S, Yuen F, Arron S, editors. Skin care in radiation oncology. Springer; 2016.
38.
Bennardo L, Passante M, Cameli N, Cristaudo A, Patruno C, Nisticò SP, et al. Skin manifestations after ionizing radiation exposure: a systematic review. Bioengineering (Basel). 2021;8:153.PubMedCrossRef
39.
Turesson I, Nyman J, Qvarnstrom F, Simonsson M, Book M, Hermansson I, et al. A low-dose hypersensitive keratinocyte loss in response to fractionated radiotherapy is associated with growth arrest and apoptosis. Radiother Oncol. 2010;94:90–101.PubMedCrossRef
40.
Turesson I, Thames HD. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year’s follow-up. Radiother Oncol. 1989;15:169–88.PubMedCrossRef
41.
Aguado-Flor E, Fuentes-Raspall MJ, Gonzalo R, Alonso C, Ramón Y, Cajal T, Fisas D, et al. Cell senescence-related pathways are enriched in breast cancer patients with late toxicity after radiotherapy and low radiation-induced lymphocyte apoptosis. Front Oncol. 2022;12:825703.PubMedPubMedCentralCrossRef
42.
43.
Julka-Anderson N. Structural racism in radiation induced skin reaction toxicity scoring. J Med Imaging Radiat Sci. 2023;54:S44–8.PubMedCrossRef
44.
Wounds U. Best practice statement: addressing skin tone bias in wound care: assessing signs and symptoms in people with dark skin tones. London; 2021.
45.
Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118:635–48.PubMedCrossRef
46.
Strachan LR, Ghadially R. Tiers of clonal organization in the epidermis: the epidermal proliferation unit revisited. Stem Cell Rev. 2008;4:149–57.PubMedCrossRef
47.
Mornex F, Pavy JJ, Denekamp J, Bolla M. Scoring system of late effects of radiations on normal tissues: the SOMA-LENT scale. Cancer Radiother. 1997;1:622–68.PubMedCrossRef
48.
Dische S, Warburton MF, Jones D, Lartigau E. The recording of morbidity related to radiotherapy. Radiother Oncol. 1989;16:103–8.PubMedCrossRef
49.
Cox J, Stetz JP. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organisation for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–6.PubMedCrossRef
50.
Institute NC. Common Terminology Criteria for Adverse Events (CTCAE) Version 5. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2017.
51.
Russi EG, Bensadoun RJ, Merlano MC, Bourhis J, Ricardi U, Giralt J, et al. Bio-radiation dermatitis: the need of a new grading: in regard to Bernier et al: Ann Oncol 2011; 22(10): 2191–2200. Ann Oncol. 2013;24:2463–5.PubMedCrossRef
52.
Bernier J, Russi EG, Homey B, Merlano MC, Mesia R, Peyrade F, et al. Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines. Ann Oncol. 2011;22:2191–200.PubMedCrossRef
53.
Lopez E, Nunez MI, Guerrero MR, del Moral R, de Dios LJ, del Mar RM, et al. Breast cancer acute radiotherapy morbidity evaluated by different scoring systems. Breast Cancer Res Treat. 2002;73:127–34.PubMedCrossRef
54.
Russi EG, Moretto F, Rampino M, Benasso M, Bacigalupo A, De Sanctis V, et al. Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: literature review and consensus. Crit Rev Oncol Hematol. 2015;96:167–82.PubMedCrossRef
55.
Cabezon-Gutierrez L, Khosravi-Shahi P, Escobar-Alvarez Y. Management of dermatitis in patients with locally advanced squamous cell carcinoma of the head and neck receiving cetuximab and radiotherapy. Oral Oncol. 2012;48:293–7.PubMedCrossRef
56.
Bhangoo RS, Cheng TW, Petersen MM, Thorpe CS, DeWees TA, Anderson JD, et al. Radiation recall dermatitis: a review of the literature. Semin Oncol. 2022;49:152–9.PubMedCrossRef
57.
Lee TF, Liu YH, Chang CH, Chiu CL, Lin CH, Shao JC, et al. Development of a risk prediction model for radiation dermatitis following proton radiotherapy in head and neck cancer using ensemble machine learning. Radiat Oncol. 2024;19:78.PubMedPubMedCentralCrossRef
58.
Yang H, Zhang Y, Heng F, Li W, Feng Y, Tao J, et al. Risk prediction model for radiation-induced dermatitis in patients with cervical carcinoma undergoing chemoradiotherapy. Asian Nurs Res (Korean Soc Nurs Sci). 2024;18:178–87.PubMed
59.
Cilla S, Romano C, Macchia G, Boccardi M, Pezzulla D, Buwenge M, et al. Machine-learning prediction model for acute skin toxicity after breast radiation therapy using spectrophotometry. Front Oncol. 2022;12:1044358.PubMedCrossRef
60.
Mukesh MB, Qian W, Wah Hak CC, Wilkinson JS, Barnett GC, Moody AM, et al. The Cambridge breast intensity-modulated radiotherapy trial: comparison of clinician-versus patient-reported outcomes. Clin Oncol (R Coll Radiol). 2016;28:354–64.PubMedCrossRef
61.
Chernyshov PV, Lallas A, Tomas-Aragones L, Arenbergerova M, Samimi M, Manolache L, et al. Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer. J Eur Acad Dermatol Venereol. 2019;33:816–27.PubMedCrossRef
62.
Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, et al. Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). J Natl Cancer Inst. 2014;106:dju244.PubMedPubMedCentralCrossRef
63.
Probst H, Rosbottom K, Crank H, Stanton A, Reed H. The patient experience of radiotherapy for breast cancer: a qualitative investigation as part of the SuPPORT 4 All study. Radiography (Lond). 2021;27:352–9.PubMedCrossRef
64.
Noble-Adams R. Radiation-induced skin reactions. 2: Development of a measurement tool. Br J Nurs. 1999;8:1208–11.PubMedCrossRef
65.
Berthelet E, Truong PT, Musso K, Grant V, Kwan W, Moravan V, et al. Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy. Am J Clin Oncol. 2004;27:626–31.PubMedCrossRef
66.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.PubMedCrossRef
67.
Loo WJ, Diba V, Chawla M, Finlay AY. Dermatology Life Quality Index: influence of an illustrated version. Br J Dermatol. 2003;148:279–84.PubMedCrossRef
68.
Fairweather D, Taylor R, Simoes R. Choosing the right questions—a systematic review of patient reported outcome measures used in radiotherapy and proton beam therapy. Radiother Oncol. 2023;191:110071.PubMedCrossRef
69.
Siddiqui F, Movsas B. Management of radiation toxicity in head and neck cancers. Semin Radiat Oncol. 2017;27:340–9.PubMedCrossRef
70.
Iacovelli NA, Torrente Y, Ciuffreda A, Guardamagna VA, Gentili M, Giacomelli L, et al. Topical treatment of radiation-induced dermatitis: current issues and potential solutions. Drugs Context. 2020;9:4–7.CrossRef
71.
Maurer M, Rietzler M, Burghardt R, Siebenhaar F. The male beard hair and facial skin—challenges for shaving. Int J Cosmet Sci. 2016;38(Suppl 1):3–9.PubMedCrossRef
72.
Kumar S, Juresic E, Barton M, Shafiq J. Management of skin toxicity during radiation therapy: a review of the evidence. J Med Imaging Radiat Oncol. 2010;54:264–79.PubMedCrossRef
73.
McQuestion M. Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs. 2011;27:e1–17.PubMedCrossRef
74.
Campbell IR, Illingworth MH. Can patients wash during radiotherapy to the breast or chest wall? A randomized controlled trial. Clin Oncol (R Coll Radiol). 1992;4:78–82.PubMedCrossRef
75.
Roy I, Fortin A, Larochelle M. The impact of skin washing with water and soap during breast irradiation: a randomized study. Radiother Oncol. 2001;58:333–9.PubMedCrossRef
76.
Ramseier JY, Ferreira MN, Leventhal JS. Dermatologic toxicities associated with radiation therapy in women with breast cancer. Int J Womens Dermatol. 2020;6:349–56.PubMedPubMedCentralCrossRef
77.
Spasić B, Jovanović M, Golušin Z, Ivanov O, Tešanović D. Radiodermatitis - review of treatment options. Serb J Dermatol Venereol. 2018;10:71–81.
78.
Kost Y, Deutsch A, Mieczkowska K, Nazarian R, Muskat A, Hosgood HD, et al. Bacterial decolonization for prevention of radiation dermatitis: a randomized clinical trial. JAMA Oncol. 2023;9:940–5.PubMedPubMedCentralCrossRef
79.
Olsen DL, Raub W Jr, Bradley C, Johnson M, Macias JL, Love V, et al. The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy. Oncol Nurs Forum. 2001;28:543–7.PubMed
80.
Theberge V, Harel F, Dagnault A. Use of axillary deodorant and effect on acute skin toxicity during radiotherapy for breast cancer: a prospective randomized noninferiority trial. Int J Radiat Oncol Biol Phys. 2009;75:1048–52.PubMedCrossRef
81.
Bolderston A, Lloyd NS, Wong RK, Holden L, Robb-Blenderman L, Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based C. The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer. 2006;14:802–17.PubMedCrossRef
82.
Pommier P, Gomez F, Sunyach MP, D’Hombres A, Carrie C, Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol. 2004;22:1447–53.PubMedCrossRef
83.
Tenorio C, de la Mata D, Leyva JA, Poitevin-Chacon A, Queijeiro MV, Gutierrez GR, Nogueda JC, Cons LC, Hernandez YB, Sánchez DR, Cruz AA. Mexican radiation dermatitis management consensus. Rep Pract Oncol Radiother. 2022;27:914–26.PubMedPubMedCentralCrossRef
84.
Ginex PK, Backler C, Croson E, Horrell LN, Moriarty KA, Maloney C, et al. Radiodermatitis in patients with cancer: systematic review and meta-analysis. Oncol Nurs Forum. 2020;47:E225–36.PubMedCrossRef
85.
Liguori V, Guillemin C, Pesce GF, Mirimanoff RO, Bernier J. Double-blind, randomized clinical study comparing hyaluronic acid cream to placebo in patients treated with radiotherapy. Radiother Oncol. 1997;42:155–61.PubMedCrossRef
86.
Naylor W, Mallett J. Management of acute radiotherapy induced skin reactions: a literature review. Eur J Oncol Nurs. 2001;5:221–33.PubMedCrossRef
87.
Rossi AM, Nehal KS, Lee EH. Radiation-induced breast telangiectasias treated with the pulsed dye laser. J Clin Aesthet Dermatol. 2014;7:34–7.PubMedPubMedCentral
88.
Radvansky LJ, Pace MB, Siddiqui A. Prevention and management of radiation-induced dermatitis, mucositis, and xerostomia. Am J Health Syst Pharm. 2013;70:1025–32.PubMedCrossRef
89.
Duffton A, Devlin L, Tsang Y, Mast M, Leech M. Advanced practice: an ESTRO RTTC position paper. Tech Innov Patient Support Radiat Oncol. 2019;10:16–9.PubMedPubMedCentralCrossRef
90.
Lee SF, Shariati S, Caini S, Wong H, Chan AW, Gojsevic M, et al. StrataXRT for the prevention of acute radiation dermatitis in breast cancer: a systematic review and meta-analysis of randomized controlled trials. Support Care Cancer. 2023;31:515.PubMedCrossRef
91.
Najem F, Prosser S, Harris J, Beldham-Collins R, Cross S, West K. Radiation therapist-led telephone follow-up: identifying patients who require post-treatment care. J Med Radiat Sci. 2021;68:389–95.PubMedPubMedCentralCrossRef
92.
Rades D, Narvaez CA, Doemer C, Janssen S, Olbrich D, Tvilsted S, et al. Radiotherapy-related skin toxicity (RAREST-02): a randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis. Trials. 2020;21:424.PubMedPubMedCentralCrossRef
93.
Colyer H. The role of the radiotherapy treatment review radiographer. Radiography. 2000;6:253–60.CrossRef
94.
Chan DCW, Wong HCY, Riad MA, Caini S, Wolf JR, van den Hurk C, et al. Prevention of radiation dermatitis with skin hygiene and washing: a systematic review and meta-analysis. Support Care Cancer. 2023;31:294.PubMedCrossRef
95.
Chan RJ, Webster J, Chung B, Marquart L, Ahmed M, Garantziotis S. Prevention and treatment of acute radiation-induced skin reactions: a systematic review and meta-analysis of randomized controlled trials. BMC Cancer. 2014;14:53.PubMedPubMedCentralCrossRef
96.
Butcher K, Williamson K. Management of erythema and skin preservation; advice for patients receiving radical radiotherapy to the breast: a systematic literature review. J Radiother Pract. 2011;11:44–54.CrossRef
97.
Abreu AM, Fraga D, Giergowicz BB, Figueiro RB, Waterkemper R. Effectiveness of nursing interventions in preventing and treating radiotherapy side effects in cancer patients: a systematic review. Rev Esc Enferm USP. 2021;55:e03697.PubMedCrossRef
98.
Burch SE, Parker SA, Vann AM, Arazie JC. Measurement of 6-MV X-ray surface dose when topical agents are applied prior to external beam irradiation. Int J Radiat Oncol Biol Phys. 1997;38:447–51.PubMedCrossRef
Metadata
Title
Practical recommendations for the management of radiodermatitis: on behalf of the ESTRO RTT committee
Authors
Elizabeth Forde
Ludwig Van den Berghe
Monica Buijs
Antonella Cardone
Jacqueline Daly
Pierfrancesco Franco
Naman Julka-Anderson
Wolfgang Lechner
Laure Marignol
Giulia Marvaso
Heather Nisbet
Anita O’Donovan
Nicola S. Russell
Philipp Scherer
Publication date
29-03-2025
Publisher
BioMed Central
Published in
Radiation Oncology / Issue 1/2025
Electronic ISSN: 1748-717X
DOI
https://doi.org/10.1186/s13014-025-02624-9

Other articles of this Issue 1/2025

Correction: Artificial intelligence contouring in radiotherapy for organs-at-risk and lymph node areas

Longitudinal assessment of diffusion-weighted imaging during magnetic resonance-guided radiotherapy in head and neck cancer

Research trends and hot spots in the prevention and management of radiation dermatitis: a bibliometric analysis based on CiteSpace

Stereotactic radiosurgery as neuromodulation of refractory angina: an initial case series

Optimising (re-)irradiation for locally recurrent head and neck cancer: impact of dose-escalation, salvage surgery, PEG tube and biomarkers on oncological outcomes—a single centre analysis

Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer

Women’s health knowledge hub

Elevate your patient care with our comprehensive, evidence-based medical education on women's health. Designed to help you provide exceptional care for your female patients at every stage of life, we provide expert insights into topics such as reproductive health, menopause, breast cancer and sex-specific health risks and precision medicine.

Read more

Incorporating comprehensive genomic profiling into the standard-of-care for NSCLC and thyroid cancer

In this interactive webinar, experts Dr. Subbiah, Dr. Drilon, and Dr. Williams discuss best pathological practices within NSCLC and thyroid cancer, as well as how genomic testing can improve outcomes in clinical practice, using patient case studies as illustrations.

This content is intended only for US-based healthcare providers.

Supported by:
  • Illumina, Inc., and Eli Lilly and Company
Dr. Vivek Subbiah
Dr. Alexander Drilon
Dr. Michelle Williams
Developed by: Springer Healthcare
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more
Image Credits